HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection against experimental pyelonephritis by antibodies to pili.

Abstract
Bacterial pili have been shown to be an important virulence factor for urinary tract infections. In this report we relate the results of studies which evaluated the influence of antipili antibody on the susceptibility of rats to ascending pyelonephritis and on several antibody-mediated antibacterial mechanisms. Rats immunized with E. coli type 1 pili, and animals infected with E. coli developed antipili antibodies in their serum. Active or passive immunization of rats with pili protected the animals from ascending pyelonephritis. Antipili antibody did not mediate complement-dependent bacteriolysis, opsonophagocytosis or promote more rapid intravascular clearance of injected E. coli. Humoral immunity to pili did, however, effectively inhibit bacterial adherence to epithelial cells. These studies indicate that type 1 E. coli pili are immunogenic and that antipili antibodies afford protection from ascending pyelonephritis. They suggest further that a mechanism of protection is inhibition of bacterial adherence.
AuthorsF J Silverblatt, R Weinstein, P Rene
JournalScandinavian journal of infectious diseases. Supplementum (Scand J Infect Dis Suppl) Vol. 33 Pg. 79-82 ( 1982) ISSN: 0300-8878 [Print] England
PMID6127805 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antibodies, Bacterial
Topics
  • Animals
  • Antibodies, Bacterial
  • Escherichia coli (immunology)
  • Escherichia coli Infections (immunology, microbiology, prevention & control)
  • Fimbriae, Bacterial (immunology)
  • Pyelonephritis (immunology, microbiology, prevention & control)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: